ABVC BioPharma, Inc.
Assets & Liabilities
| Fiscal Year | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| FY2018 | $11.3M | $5.9M | $226.7K |
| FY2019 | $7.1M | $6.9M | $144.3K |
| FY2020 | $8.9M | $11.6M | $4.3M |
| FY2021 | $4.8M | $13.7M | $5.8M |
| FY2022 | $6.3M | $9.6M | $85.3K |
Assets & Liabilities
| Fiscal Year | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| FY2018 | $11.3M | $5.9M | $226.7K |
| FY2019 | $7.1M | $6.9M | $144.3K |
| FY2020 | $8.9M | $11.6M | $4.3M |
| FY2021 | $4.8M | $13.7M | $5.8M |
| FY2022 | $6.3M | $9.6M | $85.3K |